Low Dose Nivolumab in Adults Living With HIV on Antiretroviral Therapy

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

HIV I Infection

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Alfred Hospital - Department of Infecious Diseases, Melbourne, Victoria, Australia
Contact: Study coordinator (Clinical Research Coordinator) · clinresearch@alfred.org.au · +61 (0)3 9076 6908
Contact: Principal Investigator (James McMahon, MBBS, FRACP, MPH, PhD)
Tan Tock Seng Hospital, Singapore, Singapore
Contact: Study coordinator (Choy Chiaw Yee) · chiawyee.choy@nhghealth.com.sg · +65 6511 507
Contact: Study coordinator (Pei Ming Thong) · pei.min.thong@nhghealth.com.sg · +65 6511 5073
Contact: Principal Investigator (Chen Seong Wong)

Study leads

Sharon Lewin
Principal Investigator
University of Melbourne

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

The Tatelo Plus Study

HIV · HIV Infections

Abroad (travel likely)RecruitingPHASE1, PHASE2

Francistown, Botswana · Gaborone, Botswana

Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis

Tuberculous Meningitis · HIV I Infection

Abroad (travel likely)RecruitingPHASE2

Rio de Janeiro, Brazil · Maputo, Mozambique

#AWARE.HIV Europe: Supporting Healthcare Professionals to Find Undiagnosed HIV in European Hospitals: An Effectiveness-implementation Trial.

HIV Infection · HIV · Stigma

Abroad (travel likely)Recruiting

Ghent, Belgium · Marseille, France

Real World Use of Lenacapavir, as an add-on to an Optimized Background Regimen in France

HIV I Infection

Abroad (travel likely)Recruiting

Paris, France